METHODS COMPRISING CONTINUOUS ADMINISTRATION OF GLP-1 RECEPTOR AGONIST AND CO-ADMINISTRATION OF DRUG

Title:

METHODS COMPRISING CONTINUOUS ADMINISTRATION OF GLP-1 RECEPTOR AGONIST AND CO-ADMINISTRATION OF DRUG

Document Type and Number:

Japanese Patent JP2023038234

Kind Code:

A

Abstract:

To provide methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug.SOLUTION: Provided is a method for administering to a subject, via an implantable delivery device, a continuous subcutaneous dose of glucagon-like peptide-1 (GLP-1) analog, where a drug is orally co-administered to the subject after implantation of the implantable delivery device and during the continuous subcutaneous dosing of the GLP-1 analog.SELECTED DRAWING: None

More Like This:

JP5646848	Glycosylated GLP-1 peptide
JP5415938	Glucagon-like peptide 1 (GLP-1) pharmaceutical formulation
JP5197012	Treatment of patients with short bowel syndrome with colorectal continuity

Inventors:

Andrew Young
Michelle Baron

Application Number:

JP2023000643A

Publication Date:

March 16, 2023

Filing Date:

January 05, 2023

Export Citation:

Click for automatic bibliography generation Help

Assignee:

Intersia Therapeutics, Incorporated

International Classes:

A61K38/26; A61K31/167; A61K31/37; A61K31/40; A61K31/401; A61K31/569; A61K31/704; A61K45/00; A61P3/06; A61P7/02; A61P9/00; A61P9/12; A61P15/18; A61P43/00

Attorney, Agent or Firm:

Murayama Yasuhiko
Shinya Mihiro
Tatsuhiko Abe

Previous Patent: Systems and methods for endoscopic video enhancement, quantification and surgical guidance

Next Patent: Chemiluminescent probes for protease imaging/detection